Skip to main content
Equibles

MHUAF · Meihua International Medical Technologies Co., Ltd. · Metrics

Track MHUAF — free

Use MHUAF with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research MHUAF.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$6.86 At close · Oct 23
Rebalance outlook locked
Market Cap
$5.87M
Shares
855,595
Volume · Oct 23 113 Avg daily vol (19 sessions) 629

MHUAF metrics

38 of 122 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$6.86
Market cap
$5.87M

Price action

20 metrics
Price change (1W)
+5.5%
Price change (30D)
+5.2%
Price change (3M)
-21.8%
Price change (6M)
-18.5%
Price change (YTD)
+234.6%
Price change (1Y)
—
Trailing year
Price change (5Y)
—
52-week high
—
52-week low
—
Change from 52-week high
—
Change from 52-week low
—
Annualized volatility
165.9%
Annualized volatility (3M)
—
Beta
0.3
RSI (14D)
44.1
Price vs SMA 50
-13.4%
Price vs SMA 200
—
Avg volume (3M)
—
Relative volume
—
Average dollar volume
—

Company

3 metrics
Sector
Healthcare
Industry
Medical Instruments & Supplies
Shares outstanding
855,595

Valuation

12 metrics
P / E (TTM)
—
Trailing earnings
PEG ratio
—
EV / revenue
—
EV / EBITDA
—
EV / EBIT
—
P / sales
—
P / book
0.0
reciprocal yield 3,218.9%
FCF yield
—
TTM · current market cap
Buyback yield
—
P / FCF
—
P / operating cash flow
—
Earnings yield
—

Historical valuation

8 metrics
P / E historical average (3Y)
—
P / E historical average (5Y)
—
EV / revenue historical average (3Y)
—
EV / revenue historical average (5Y)
—
EV / EBIT historical average (3Y)
—
EV / EBIT historical average (5Y)
—
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
—

Dividends & buybacks

7 metrics
Dividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
—
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—

Earnings calendar

2 metrics
Next earnings
—
Last earnings
—

Profitability

9 metrics
Gross margin
31.0%
Operating margin
13.4%
Trailing 12 months
Net margin
11.0%
Gross profit (TTM)
—
Operating profit (TTM)
—
Net income (TTM)
—
Trailing 12 months
Diluted EPS (TTM)
—
FCF margin
—
Effective tax rate
—

Per share

11 metrics
Revenue per diluted share (TTM)
—
Gross profit per diluted share (TTM)
—
Operating profit per diluted share (TTM)
—
EBITDA per diluted share (TTM)
—
Net income per diluted share (TTM)
—
Operating cash flow per diluted share (TTM)
—
Free cash flow per diluted share (TTM)
—
Capital expenditures per diluted share (TTM)
—
R&D per diluted share (TTM)
—
Stock compensation per diluted share (TTM)
—
Book value per share
$270.71

Growth

11 metrics
Revenue growth YoY
-36.2%
Year over year
Net income growth YoY
-37.5%
Revenue (TTM)
—
Trailing 12 months
EPS growth YoY
-54.5%
Shares change YoY
+37.4%
Year over year · more shares
Revenue CAGR (3Y)
-15.8%
Revenue CAGR (5Y)
-7.1%
EPS CAGR (3Y)
-12.6%
EPS CAGR (5Y)
-28.3%
FCF CAGR (3Y)
—
FCF CAGR (5Y)
-18.2%

Quality

14 metrics
Return on equity
3.6%
Return on assets
3.3%
Debt / equity
—
Current ratio
8.4
EBITDA (TTM)
—
Free cash flow (TTM)
—
Quick ratio
8.3
Interest coverage
—
Net debt / EBITDA
—
Return on invested capital
—
Trailing 12 months
Net cash
—
Latest balance sheet
Cash & equivalents
$15.15M
Total assets
$207.18M
Total debt
—

Cash flow & spend

7 metrics
Operating cash flow (TTM)
—
Capital expenditures (TTM)
—
R&D (TTM)
—
SG&A (TTM)
—
Stock compensation (TTM)
—
R&D / revenue
—
Stock compensation / revenue
—

Ownership (13F)

9 metrics
13F filers
—
13F filer change QoQ
—
Institutional ownership
—
Conviction holders (share of 13F filers)
—
Crowding (high-turnover and private-fund holders)
—
Private-fund adviser ownership
—
Active holders' share change QoQ
—
Holder tenure
—
Price vs estimated holder cost
—

Ownership (registered funds)

1 metrics
Index-fund ownership
0.0%

Short interest

3 metrics
Short interest
0.1%
Latest settlement · 1.2 days to cover
Days to cover
1.2d
Short-squeeze score
24 / 100

Insider activity

2 metrics
Net insider buying (90D)
—
Insider-sentiment score
—

Risk flags

1 metrics
Going concern
—
Key facts CIK 1835615 CUSIP G5966G116